8 April 2005
And then there was one
I ran out of Bextra a couple weeks ago, and began looking for a replacement anti-inflammatory, on the reasonable basis that (1) the chemically-similar Vioxx had already been withdrawn from the market and (2) the third of the COX-2 inhibitors in general use, Celebrex, never did much for me.
Now Bextra is being pulled off the shelves as well, leaving Celebrex alone to carry on the product class. And buyers of Celebrex, and lots of other NSAIDs*, will be faced with a bevy of new product warnings.
Meanwhile, after unsuccessful trials with Relafen, I am in the process of switching to Mobic. It, too, will get the industrial-strength warnings. I do hope my prescription plan is amenable to the new stuff; they really hated Bextra, demanding a note from the prescribing physician in addition to the actual prescription itself, and then tacking an extra 50 percent onto the copayment.
Posted at 8:00 AM to Dyssynergy
TrackBack: 6:51 PM, 8 April 2005
» One Cox-2 Inhibitor Remaining from Personal Injury Resources
Unfortunately for this blogger, Vioxx and Bextra are off the market. Celebrex doesn't seem to do the trick.......[read more]